|
US3120564A
(en)
|
1960-01-13 |
1964-02-04 |
American Cyanamid Co |
Alkenoylamino benzophenones
|
|
US3903106A
(en)
|
1974-04-12 |
1975-09-02 |
Lilly Co Eli |
Pyrazole-3-carboxylic acids
|
|
US3895027A
(en)
*
|
1974-04-12 |
1975-07-15 |
Lilly Co Eli |
Process for preparing pyrazole-3-carboxylic acids
|
|
ZA825719B
(en)
|
1981-09-03 |
1983-06-29 |
Recordati Chem Pharm |
Alkanoylanilides
|
|
JPS58179838A
(ja)
|
1982-04-14 |
1983-10-21 |
Konishiroku Photo Ind Co Ltd |
画像形成方法
|
|
US5256791A
(en)
|
1992-03-02 |
1993-10-26 |
Pfizer Inc. |
Preparation of intermediates in the synthesis of quinoline antibiotics
|
|
CA2173326A1
(en)
*
|
1993-10-06 |
1995-04-13 |
Lucian Radu Denes |
Herbicidal heteroaryl substituted anilides
|
|
DE4341403A1
(de)
|
1993-12-04 |
1995-06-08 |
Basf Ag |
N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
|
|
US5475116A
(en)
|
1994-04-29 |
1995-12-12 |
Pfizer Inc. |
Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
|
|
JPH0912547A
(ja)
|
1995-06-23 |
1997-01-14 |
Chisso Corp |
ニューキノロン系化合物中間体の製造方法
|
|
WO1997030030A1
(en)
|
1996-02-13 |
1997-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Indole derivatives
|
|
JPH1072434A
(ja)
*
|
1996-04-08 |
1998-03-17 |
Nissan Chem Ind Ltd |
2,4−置換アニリン誘導体
|
|
US5968929A
(en)
|
1996-10-30 |
1999-10-19 |
Schering Corporation |
Piperazino derivatives as neurokinin antagonists
|
|
US7019142B2
(en)
|
1998-01-16 |
2006-03-28 |
Pfizer Inc. |
Process for preparing naphthyridones and intermediates
|
|
US6184380B1
(en)
|
1999-01-25 |
2001-02-06 |
Pfizer Inc. |
Process for preparing naphthyridones and intermediates
|
|
US6590118B1
(en)
|
1999-09-29 |
2003-07-08 |
Novo Nordisk A/S |
Aromatic compounds
|
|
HUP0301391A3
(en)
|
2000-02-11 |
2010-03-29 |
Vertex Pharma |
Piperazine and piperidine derivatives pharmaceutical compositions containing them and their use
|
|
EP1184372B1
(en)
|
2000-08-31 |
2006-04-26 |
Pfizer Limited |
Phenoxyphenylheterocycle derivatives as selective serotonin reuptake inhibitors (SSRIs)
|
|
CZ20031013A3
(en)
|
2000-10-19 |
2004-03-17 |
Pfizer Products Inc. |
Bridged piperazine derivatives
|
|
GEP20053675B
(en)
|
2001-03-30 |
2005-11-25 |
Pfizer Prod Inc |
Pyridazinone Aldose Reductase Inhibitors
|
|
CN100506817C
(zh)
|
2001-08-15 |
2009-07-01 |
纳幕尔杜邦公司 |
用于防治无脊椎害虫的邻-杂环取代的芳基酰胺类化合物
|
|
US20040034019A1
(en)
|
2002-08-08 |
2004-02-19 |
Ronald Tomlinson |
Piperazine and piperidine derivatives
|
|
US20040082641A1
(en)
|
2002-10-28 |
2004-04-29 |
Rytved Klaus Asger |
Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
|
|
JP2006507359A
(ja)
|
2002-10-28 |
2006-03-02 |
ノボ・ノルデイスク・エー/エス |
心循環器疾患の治療のためのグリコーゲンホスホリラーゼ阻害剤の使用
|
|
AU2002353286A1
(en)
|
2002-12-10 |
2004-06-30 |
Ranbaxy Laboratories Limited |
3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
|
|
AU2002347553A1
(en)
|
2002-12-23 |
2004-07-14 |
Ranbaxy Laboratories Limited |
Flavaxate derivatives as muscarinic receptor antagonists
|
|
EP1590345A1
(en)
|
2002-12-23 |
2005-11-02 |
Ranbaxy Laboratories, Ltd. |
Xanthine derivatives as muscarinic receptor antagonists
|
|
US7488748B2
(en)
|
2003-01-28 |
2009-02-10 |
Ranbaxy Laboratories Limited |
3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
|
|
EA009903B1
(ru)
|
2003-10-14 |
2008-04-28 |
Пфайзер Продактс Инк. |
Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина
|
|
AU2005212073B2
(en)
|
2004-02-18 |
2010-07-08 |
Kyorin Pharmaceutical Co., Ltd. |
Bicyclic amide derivatives
|
|
WO2006002133A1
(en)
|
2004-06-22 |
2006-01-05 |
Schering Corporation |
Cannabinoid receptor ligands
|
|
DE102004039280A1
(de)
*
|
2004-08-13 |
2006-02-23 |
Merck Patent Gmbh |
1,5-Diphenyl-pyrazole
|
|
WO2006024955A1
(en)
|
2004-09-01 |
2006-03-09 |
Pfizer Products Inc. |
Azabicyclic amine histamine-3 receptor antagonists
|
|
WO2006054162A1
(en)
|
2004-11-19 |
2006-05-26 |
Ranbaxy Laboratories Limited |
Azabicyclic muscarinic receptor antagonists
|
|
CN1944398A
(zh)
|
2005-01-11 |
2007-04-11 |
中国医学科学院药物研究所 |
新的苯甲酰胺类化合物及其制法和药物用途
|
|
MX2007012463A
(es)
|
2005-04-08 |
2007-11-07 |
Pfizer Prod Inc |
Heteroarilamidas[3.1.0]biciclicas como inhibidores del transporte de glicina de tipo i.
|
|
US20090124600A1
(en)
|
2005-04-19 |
2009-05-14 |
Layton Mark E |
N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists
|
|
CN101218235A
(zh)
|
2005-05-10 |
2008-07-09 |
沃泰克斯药物股份有限公司 |
作为离子通道调控剂的二环衍生物
|
|
GB0510204D0
(en)
|
2005-05-19 |
2005-06-22 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
EP1931633A2
(en)
|
2005-09-05 |
2008-06-18 |
Ranbaxy Laboratories Limited |
Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-iv inhibitors
|
|
WO2007045979A1
(en)
|
2005-10-19 |
2007-04-26 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of muscarinic receptor antagonists
|
|
US7560551B2
(en)
|
2006-01-23 |
2009-07-14 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
|
WO2008010061A2
(en)
|
2006-07-17 |
2008-01-24 |
Glenmark Pharmaceuticals S.A. |
3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
|
|
AU2007274598A1
(en)
|
2006-07-21 |
2008-01-24 |
Lupin Limited |
Antidiabetic azabicyclo [3. 1. 0] hexan compounds
|
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
|
WO2008029349A2
(en)
|
2006-09-04 |
2008-03-13 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
|
JP2010513458A
(ja)
|
2006-12-19 |
2010-04-30 |
ファイザー・プロダクツ・インク |
H−pgdsの阻害剤としてのニコチンアミド誘導体、およびプロスタグランジンd2の仲介による疾患を治療するためのその使用
|
|
CA2679198C
(en)
|
2007-02-26 |
2011-07-12 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
WO2008117229A1
(en)
|
2007-03-23 |
2008-10-02 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
|
PE20091017A1
(es)
|
2007-10-31 |
2009-07-16 |
Janssen Pharmaceutica Nv |
Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
|
|
WO2009090548A2
(en)
|
2008-01-17 |
2009-07-23 |
Glenmark Pharmaceuticals, S.A. |
3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
|
|
WO2009152027A1
(en)
|
2008-06-12 |
2009-12-17 |
Merck & Co., Inc. |
5,7-dihydro-6h-pyrrolo[2,3-d]pyrimidin-6-one derivatives for mark inhibition
|
|
CA2957226C
(en)
|
2008-10-29 |
2018-08-14 |
Celgene Corporation |
Isoindoline compounds for use in the treatment of cancer
|
|
MX2011010200A
(es)
|
2009-04-08 |
2011-10-14 |
Actelion Pharmaceuticals Ltd |
6-(3-aza-biciclo[3.1.0]hex-3-il)-2fenil-pirimidinas como antagonistas del receptor de adenosina 5'-difosfato (adp).
|
|
US9149465B2
(en)
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
AR076687A1
(es)
|
2009-05-18 |
2011-06-29 |
Infinity Pharmaceuticals Inc |
Isoxazolinas como inhibidores de la amidahidrolasa de acidos grasos y com-posiciones farmaceuticas que los contienen
|
|
CA2805427A1
(en)
|
2010-07-23 |
2012-01-26 |
Merck Sharp & Dohme Corp. |
Novel pyrrolidine derived beta 3 adrenergic receptor agonists
|
|
US20170119786A1
(en)
|
2011-03-08 |
2017-05-04 |
3-V Biosciences, Inc. |
Heterocyclic modulators of lipid synthesis
|
|
WO2013018929A1
(en)
|
2011-08-04 |
2013-02-07 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing heterocyclic compound
|
|
WO2013039802A1
(en)
|
2011-09-16 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
DK2758394T3
(en)
|
2011-09-19 |
2015-04-20 |
Suven Life Sciences Ltd |
HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS
|
|
WO2013118138A1
(en)
|
2011-12-13 |
2013-08-15 |
Laboratories Ltd Mylan |
Novel process for the preparation of renin inhibitors
|
|
TWI566701B
(zh)
|
2012-02-01 |
2017-01-21 |
日本農藥股份有限公司 |
芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
|
|
WO2014085210A1
(en)
|
2012-11-29 |
2014-06-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
AU2014249233A1
(en)
|
2013-03-13 |
2015-09-24 |
The Regents Of The University Of Michigan |
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
MX2015012822A
(es)
|
2013-03-14 |
2016-05-31 |
Novartis Ag |
3-pirimidin-4-il-oxazolidin-2-onas- como inhibidores del idh mutante.
|
|
KR101556318B1
(ko)
|
2013-05-15 |
2015-10-01 |
한국과학기술연구원 |
칼슘이온 채널 조절제로서 유효한 6-피라졸일아미도-3-치환된 아자바이사이클로[3.1.0]헥산 유도체
|
|
WO2014199164A1
(en)
|
2013-06-12 |
2014-12-18 |
Ampla Pharmaceuticals, Inc. |
Diaryl substituted heteroaromatic compounds
|
|
EP3193880B1
(en)
|
2014-09-19 |
2020-03-25 |
Eli Lilly and Company |
Inhibiting the transient receptor potential a1 ion channel
|
|
CN104370899A
(zh)
|
2014-10-23 |
2015-02-25 |
南京工业大学 |
一种含1,2,4-噁二唑结构的甲酰苯胺类化合物及其制备方法与应用
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|
|
AR105889A1
(es)
|
2015-09-03 |
2017-11-22 |
Actelion Pharmaceuticals Ltd |
Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
|
|
WO2017053706A1
(en)
|
2015-09-23 |
2017-03-30 |
The General Hospital Corporation |
Tead transcription factor autopalmitoylation inhibitors
|
|
WO2017058716A1
(en)
|
2015-09-28 |
2017-04-06 |
Vivace Therapeutics, Inc. |
Tricyclic compounds
|
|
EP3156404A1
(en)
|
2015-10-15 |
2017-04-19 |
Inventiva |
New compounds inhibitors of the yap/taz-tead interaction and their use in the treatment of malignant mesothelioma
|
|
US20170158702A1
(en)
|
2015-12-02 |
2017-06-08 |
Kyras Therapeutics, Inc. |
Multivalent ras binding compounds
|
|
TWI804987B
(zh)
|
2015-12-24 |
2023-06-11 |
日商協和麒麟股份有限公司 |
α、β不飽和醯胺化合物
|
|
TN2018000198A1
(en)
|
2015-12-29 |
2019-10-04 |
Pfizer |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
|
|
JP6990663B2
(ja)
|
2016-05-31 |
2022-01-13 |
シエッシ ファーマスーティシ エス.ピー.エー. |
ヒト好中球エラスターゼ阻害剤としてのイミダゾロン化合物
|
|
WO2017210545A1
(en)
|
2016-06-02 |
2017-12-07 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
|
CA3028949C
(en)
|
2016-06-27 |
2020-10-27 |
Korea Research Institute Of Chemical Technology |
Pyridine-based compound including isoxazoline ring and use thereof as herbicide
|
|
AU2017316639B2
(en)
|
2016-08-23 |
2022-09-08 |
Recurium Ip Holdings, Llc |
Methods for cross coupling
|
|
SI3526202T1
(sl)
|
2016-10-11 |
2025-04-30 |
Arvinas Operations, Inc. |
Spojine in postopki za ciljno razgradnjo androgenskih receptorjev
|
|
WO2018102751A1
(en)
|
2016-12-02 |
2018-06-07 |
Quentis Therapeutics, Inc. |
Ire1 small molecule inhibitors
|
|
WO2018136437A2
(en)
|
2017-01-17 |
2018-07-26 |
Tesaro, Inc. |
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
|
|
AU2018249675B2
(en)
|
2017-04-06 |
2021-08-19 |
Inventiva |
New compounds inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma.
|
|
US11186554B2
(en)
|
2017-05-03 |
2021-11-30 |
Vivace Therapeutics, Inc. |
Non-fused tricyclic compounds
|
|
WO2018208987A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
SG11201912770SA
(en)
|
2017-06-23 |
2020-01-30 |
Kyowa Kirin Co Ltd |
a, ß-UNSATURATED AMIDE COMPOUND
|
|
WO2019040380A1
(en)
|
2017-08-21 |
2019-02-28 |
Vivace Therapeutics, Inc. |
BENZOSULFONYL COMPOUNDS
|
|
TWI793151B
(zh)
|
2017-08-23 |
2023-02-21 |
瑞士商諾華公司 |
3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
|
|
TW201920108A
(zh)
|
2017-09-25 |
2019-06-01 |
日商武田藥品工業有限公司 |
N-(氰基取代之苄基或吡啶基甲基)-3-羥基吡啶醯胺衍生物
|
|
US10287222B1
(en)
|
2017-10-20 |
2019-05-14 |
Uop Llc |
Process and apparatus for desorbent recovery
|
|
JP7212693B2
(ja)
|
2017-11-01 |
2023-01-25 |
ブリストル-マイヤーズ スクイブ カンパニー |
ファルネソイドx受容体モジュレーターとしての架橋二環化合物
|
|
US11168079B2
(en)
|
2017-11-01 |
2021-11-09 |
Bristol-Myers Squibb Company |
Alkene compounds as farnesoid x receptor modulators
|
|
WO2019113236A1
(en)
|
2017-12-06 |
2019-06-13 |
Vivace Therapeutics, Inc. |
Benzocarbonyl compounds
|
|
CA3090130A1
(en)
|
2018-02-02 |
2019-08-08 |
Vanderbilt University |
Antagonists of the muscarinic acetylcholine receptor m4
|
|
WO2019195959A1
(en)
|
2018-04-08 |
2019-10-17 |
Cothera Biosciences, Inc. |
Combination therapy for cancers with braf mutation
|
|
WO2019204505A2
(en)
|
2018-04-18 |
2019-10-24 |
Theras, Inc. |
K-ras modulators with a vinyl sulfonamide moiety
|
|
JP7394074B2
(ja)
|
2018-05-31 |
2023-12-07 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
治療用化合物
|
|
TW202024023A
(zh)
|
2018-09-03 |
2020-07-01 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|
|
US12421210B2
(en)
|
2018-10-05 |
2025-09-23 |
New York University |
Fused bicyclic heterocycles as therapeutic agents
|
|
EP3867242A1
(en)
|
2018-10-15 |
2021-08-25 |
Nurix Therapeutics, Inc. |
Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
|
|
US12698259B2
(en)
|
2018-10-15 |
2026-08-04 |
Dana-Farber Cancer Institute, Inc. |
Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof
|
|
US20210403415A1
(en)
|
2018-10-26 |
2021-12-30 |
The Trustees Of Indiana University |
Compounds and methods to attenuate tumor progression and metastasis
|
|
TWI835945B
(zh)
|
2018-12-14 |
2024-03-21 |
南韓商柳韓洋行股份有限公司 |
3,3-二氟烯丙胺化物或其鹽及包含彼的醫藥組合物
|
|
EP3924054B1
(en)
|
2019-02-15 |
2025-04-02 |
Novartis AG |
3-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
|
|
JP2022525186A
(ja)
|
2019-03-15 |
2022-05-11 |
ザ ジェネラル ホスピタル コーポレイション |
Tead転写因子新規小分子阻害剤
|
|
ES3055186T3
(en)
|
2019-04-04 |
2026-02-10 |
Dana Farber Cancer Inst Inc |
Bifunctional compounds comprising a cdk2/5 ligand, a linker and a e3 ubiquitin ligase binding degron for the treatment of cancer
|
|
JP2022529700A
(ja)
|
2019-04-23 |
2022-06-23 |
ダナ-ファーバー キャンサー インスティテュート,インコーポレイテッド |
サイクリン依存性キナーゼ12(cdk12)の分解剤およびその使用
|
|
US11458149B1
(en)
|
2019-05-31 |
2022-10-04 |
Ikena Oncology, Inc. |
TEAD inhibitors and uses thereof
|
|
BR112021024108A2
(pt)
|
2019-05-31 |
2022-03-22 |
Ikena Oncology Inc |
Inibidores de tead e usos dos mesmos
|
|
MA56022A
(fr)
|
2019-05-31 |
2022-04-06 |
Chiesi Farm Spa |
Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3
|
|
CR20210587A
(es)
|
2019-05-31 |
2022-02-11 |
Janssen Pharmaceutica Nv |
Inhibidores de molécula pequeña de quinasa inductora de nf-kb
|
|
SI4299135T1
(sl)
|
2019-06-18 |
2025-12-31 |
Pfizer Inc. |
Benzizoksazolni sulfonamidni derivati
|
|
EP4058435A1
(en)
|
2019-11-13 |
2022-09-21 |
Genentech, Inc. |
Therapeutic compounds and methods of use
|
|
PH12022551379A1
(en)
|
2019-12-06 |
2023-05-03 |
Vertex Pharma |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
CA3162348A1
(en)
|
2019-12-24 |
2021-07-01 |
Nathanael S. Gray |
Transcriptional enhanced associate domain (tead) transcription factor inhibitors and uses thereof
|
|
CN115210227A
(zh)
|
2020-03-04 |
2022-10-18 |
基因泰克公司 |
作为tead抑制剂的异双功能分子
|
|
US20240124406A1
(en)
|
2020-06-03 |
2024-04-18 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcriptional enhanced associate domain (tead) and uses thereof
|
|
WO2022120353A1
(en)
|
2020-12-02 |
2022-06-09 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|
|
WO2022120355A1
(en)
|
2020-12-02 |
2022-06-09 |
Ikena Oncology, Inc. |
Tead degraders and uses thereof
|
|
EP4255895A1
(en)
|
2020-12-02 |
2023-10-11 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|
|
BR112023014751A2
(pt)
|
2021-01-25 |
2023-10-03 |
Ikena Oncology Inc |
Combinação de um inibidor de tead de 3-(imidazol-4-il)-4-(amino)-benzenossulfonamida com um inibidor de egfr e/ou inibidor de mek para uso no tratamento de câncer de pulmão
|
|
WO2023060227A1
(en)
|
2021-10-07 |
2023-04-13 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|
|
WO2023114984A1
(en)
|
2021-12-17 |
2023-06-22 |
Ikena Oncology, Inc. |
Tead inhibitors and uses thereof
|